Brentuximab

Name: Brentuximab

Brentuximab Overview

Brentuximab is a prescription medication used to treat Hodgkin's lymphoma and systemic anaplastic large cell lymphoma (sALCL; a type of non-Hodgkin lymphoma) when other treatments have not been successful. This medication belongs to a group of drugs called antibody-drug conjugates. It attaches to and enters cancer cells and kills them.

Brentuximab comes in an injectable form to be given directly into a vein and infused over 30 minutes by a healthcare provider. It is usually injected once every 3 weeks.

Common side effects include tiredness, nausea, and diarrhea.

Brentuximab Brand Names

Brentuximab may be found in some form under the following brand names:

  • Adcetris

Side Effects of Brentuximab

Common side effects include:

  • tiredness
  • nausea
  • diarrhea
  • low white blood cell counts
  • anemia
  • tingling sensation

This is not a complete list of brentuximab side effects. Ask your doctor or pharmacist for more information.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Brentuximab Overdose

Since this medication is administered by a healthcare provider in a medical setting, it is unlikely that an overdose will occur. However, if overdose is suspected, seek emergency medical attention.

(web3)